These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 6650978

  • 1. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.
    Ahn CH, Lowell JR, Ahn SS, Ahn SI, Hurst GA.
    Am Rev Respir Dis; 1983 Dec; 128(6):1048-50. PubMed ID: 6650978
    [Abstract] [Full Text] [Related]

  • 2. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease.
    Santin M, Dorca J, Alcaide F, Gonzalez L, Casas S, Lopez M, Guerra MR.
    Eur Respir J; 2009 Jan; 33(1):148-52. PubMed ID: 19118226
    [Abstract] [Full Text] [Related]

  • 3. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
    Snider DE, Zierski M, Graczyk J, Bek E, Farer LS.
    Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
    [Abstract] [Full Text] [Related]

  • 4. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
    Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin].
    Suzuyama Y, Shigeno Y, Shigeno H, Nakazato H, Nagasawa M, Koga H, Tomita H, Tomonaga A, Yamaguchi K, Izumikawa K.
    Kekkaku; 1984 Apr; 59(4):277-87. PubMed ID: 6748457
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Short-term initial chemotherapy with isoniazid, rifampin and ethambutol (streptomycin) in biphasic (3+6) administration, from the intermittent (2/7) beginning. Results after 2 years (cooperative experiment)].
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977 Apr; 26(2):79-90. PubMed ID: 195328
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pulmonary Infection Caused by Mycobacterium shinjukuense.
    Oshima K, Yokouchi H, Minemura H, Saito J, Tanino Y, Munakata M.
    Ann Am Thorac Soc; 2015 Jun; 12(6):958-9. PubMed ID: 26075560
    [No Abstract] [Full Text] [Related]

  • 14. [Short-course treatment of pulmonary tuberculosis: comparison with a classical standard regimen].
    Bouslama A, Hedhiri H, Marzouki M, Jerray M, Djenayah F.
    Bull Int Union Tuberc; 1985 Jun; 60(1-2):29-30. PubMed ID: 4074969
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rifampin-resistant Mycobacterium kansasii.
    Wallace RJ, Dunbar D, Brown BA, Onyi G, Dunlap R, Ahn CH, Murphy DT.
    Clin Infect Dis; 1994 May; 18(5):736-43. PubMed ID: 8075262
    [Abstract] [Full Text] [Related]

  • 19. [Intensive chemotherapy of pulmonary tuberculosis].
    Shesterina MV, Gavrilenko VS, Tarasova EF, Sokolova GV, Tregubov IuG.
    Probl Tuberk; 1980 Jul; (7):20-22. PubMed ID: 6997865
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.